Vaccinium dunalianum Leaf Extract (国妆原备字20260149)
Official China NMPA New Cosmetic Ingredient Filing Dossier: Filing No. 国妆原备字20260149 (樟叶越橘（VACCINIUM DUNALIANUM）枝/叶提取物) · Filed by 云南远方生物医药有限公司 on —.
Vaccinium dunalianum Leaf Extract (Official Chinese Name: 樟叶越橘（VACCINIUM DUNALIANUM）枝/叶提取物) was officially filed with China’s National Medical Products Administration (NMPA) on 2026年9月28日 under filing number 国妆原备字20260149 by 云南远方生物医药有限公司 (Domestic (China)). Under China’s CSAR regulatory framework, this ingredient is currently in its mandatory 3-year post-market safety monitoring window (projected IECIC catalog inclusion date: 2029年9月28日).
| NMPA Dossier Field | Official Filing Data & Status | Sourcing & Formulation Implication |
|---|---|---|
| NMPA Filing Number | 国妆原备字20260149 | Active filing under China CSAR new ingredient registry |
| English / INCI Reference | Vaccinium dunalianum Leaf Extract | Standardized cross-border R&D and COA lookup name |
| Official Name in Chinese | 樟叶越橘（VACCINIUM DUNALIANUM）枝/叶提取物 | Mandatory Chinese label name for China market entry |
| Registered Filer Entity | 云南远方生物医药有限公司 | Authorization required from filer during 3-year monitoring |
| Filing Date & 3-Yr Window | Filed: 2026年9月28日 → IECIC Inclusion Target: 2029年9月28日 | Transitions to open IECIC catalog after 3 years without safety alerts |
| Target Turnkey Formats | BFS Single-Dose Ampoules / Hydrogel Masks / Dissolving Microneedle Patches | Available for global export OEM formulation & compliant alternatives |
Official Chinese INCI Names (IECIC) & 2026 Supply Lead-Time Quick Reference
| INCI Name | Official Name in Chinese (NMPA IECIC) | 2026 Supply Disruption, Stockout & Lead-Time Status | US FDA / EU CosIng Limit & Turnkey OEM Formats |
|---|---|---|---|
| Bakuchiol | 补骨脂酚 (Bǔ Gǔ Zhī Fēn) | ⚠️ Botanical seed-extracted grade (≥99%): 4–6 wk lead time (seasonal crop price fluctuations). Bio-fermented grade: No stockout / 2-wk lead time. | Clean retinol alternative; no EU Annex III cap. Top formats: Unit-dose barrier serum pods & hydrogel eye masks. |
| Colloidal Oatmeal | 胶体燕麦 / 燕麦 (AVENA SATIVA) 仁粉 | ✅ Stable supply (2–3 wk lead time); zero force majeure alerts. Ultra-fine USP grade requires verified beta-glucan COA. | US FDA OTC Skin Protectant Monograph active. Top formats: Soothing hydrocolloid barrier patches & single-serve cream pods. |
| Alpha-Arbutin | α-熊果苷 (Alpha-Xióng Guǒ Gān) | ⚠️ High demand ahead of EU reformulation deadlines (3–4 wk lead time); requires Hydroquinone impurity < 10 ppm. | EU CosIng Annex III limit: ≤ 2.0% face cream, ≤ 0.5% body lotion. Top format: Light-shielded single-dose brightening ampoules. |
| Salicylic Acid | 水杨酸 (Shuǐ Yáng Suān) | ✅ Ample global capacity (2 wk lead time); encapsulated & micronized patch-grade demand up +65% YoY. | US FDA OTC Acne Monograph (0.5%–2.0%); EU Annex III ≤ 2.0%. Top format: OTC hydrocolloid & microneedle acne patches. |
| Sodium DNA (PDRN) | DNA 钠 (DNA Nà) | 🔥 Tight lead time on pharmaceutical salmon-trout grade (5–7 wks); vegan ginseng/microalgae PDRN scaling rapidly. | K-Beauty Olive Young #1 surge ingredient. Top format: Dissolving microneedle patches & sterile BFS unit-dose vials. |
Pick your category — get recalls & regulation alerts weekly
Leave your email and the category you make: each week we tell you what was recalled or noticed in the EU and US, which deadlines are close, and who just raised money. Or use RSS. Free; unsubscribe anytime.
- EU recalls and US Prop 65 notices in your category
- Upcoming regulatory deadlines
- Opportunities filtered for your role